Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

The Relationship Between Biopharma R&D Investment and Expected Returns: Improving Evidence to Inform Policy

May 6, 2024

Information Technology & Innovation Foundation

By Kirsten Axelsen and Sandra Barbosu

Medicare Reform Initiative

May 1, 2024

Paragon Health Institute

Myths v. Facts Can Bayh-Dole March-In Rights Lower Drug Costs?

April 4, 2024

Bayh-Dole Coalition

Not Again: Why the United States Can’t Afford to Lose Its Biopharma Industry

February 29, 2024

Information Technology & Innovation Foundation

By Sandra Barbosu

What Universities Are Saying About the Biden Administration’s Draft Framework for March-In Rights

February 13, 2024

Bayh-Dole Coalition

Scroll to Top